SIRT1 and type 2 diabetes mellitus: Thus, there is a vicious cycle among oxidative stress, inflammation and mitochondrial dysfunction, and breaking this cycle may be a therapeutic target for the treatment of age-related insulin resistance and T2DM, focusing on SIRT1, SIRT2, SIRT3, and SIRT6 (Figure 1).